191 related articles for article (PubMed ID: 19325006)
1. The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression.
Jodhka PK; Kaur P; Underwood W; Lydon JP; Singh M
Endocrinology; 2009 Jul; 150(7):3162-8. PubMed ID: 19325006
[TBL] [Abstract][Full Text] [Related]
2. Progesterone, compared to medroxyprogesterone acetate, to C57BL/6, but not 5α-reductase mutant, mice enhances object recognition and placement memory and is associated with higher BDNF levels in the hippocampus and cortex.
Frye CA; Koonce CJ; Walf AA
Neurosci Lett; 2013 Sep; 551():53-7. PubMed ID: 23872095
[TBL] [Abstract][Full Text] [Related]
3. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling.
Nilsen J; Brinton RD
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10506-11. PubMed ID: 12925744
[TBL] [Abstract][Full Text] [Related]
4. Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.
Su C; Cunningham RL; Rybalchenko N; Singh M
Endocrinology; 2012 Sep; 153(9):4389-400. PubMed ID: 22778217
[TBL] [Abstract][Full Text] [Related]
5. Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants.
Kaur P; Jodhka PK; Underwood WA; Bowles CA; de Fiebre NC; de Fiebre CM; Singh M
J Neurosci Res; 2007 Aug; 85(11):2441-9. PubMed ID: 17549730
[TBL] [Abstract][Full Text] [Related]
6. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate.
Nilsen J; Brinton RD
Endocrinology; 2002 Jan; 143(1):205-12. PubMed ID: 11751611
[TBL] [Abstract][Full Text] [Related]
7. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
8. Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells.
Tseng L; Zhu HH
Biol Reprod; 1997 Dec; 57(6):1360-6. PubMed ID: 9408241
[TBL] [Abstract][Full Text] [Related]
9. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
10. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
11. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
12. The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.
Ghatge RP; Jacobsen BM; Schittone SA; Horwitz KB
Breast Cancer Res; 2005; 7(6):R1036-50. PubMed ID: 16457685
[TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity.
Nilsen J; Morales A; Brinton RD
Gynecol Endocrinol; 2006 Jul; 22(7):355-61. PubMed ID: 16864144
[TBL] [Abstract][Full Text] [Related]
14. Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.
Montero Girard G; Vanzulli SI; Cerliani JP; Bottino MC; Bolado J; Vela J; Becu-Villalobos D; Benavides F; Gutkind S; Patel V; Molinolo A; Lanari C
Breast Cancer Res; 2007; 9(2):R22. PubMed ID: 17341305
[TBL] [Abstract][Full Text] [Related]
15. Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy.
Singh M; Su C
Brain Res; 2013 Jun; 1514():98-106. PubMed ID: 23340161
[TBL] [Abstract][Full Text] [Related]
16. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective.
Ciriza I; Carrero P; Frye CA; Garcia-Segura LM
J Neurobiol; 2006 Aug; 66(9):916-28. PubMed ID: 16758493
[TBL] [Abstract][Full Text] [Related]
17. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Beranič N; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of progesterone and the synthetic progestin medroxyprogesterone acetate on vascular remodeling.
Cutini PH; Massheimer VL
Mol Cell Endocrinol; 2019 Dec; 498():110543. PubMed ID: 31421164
[TBL] [Abstract][Full Text] [Related]
19. Progestins and neuroprotection: are all progestins created equal?
Singh M
Minerva Endocrinol; 2007 Jun; 32(2):95-102. PubMed ID: 17557035
[TBL] [Abstract][Full Text] [Related]
20. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
